Literature DB >> 11782990

Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema.

John R Lynch1, Jose A Pineda, Duncan Morgan, Lin Zhang, David S Warner, Helen Benveniste, Daniel T Laskowitz.   

Abstract

Apolipoprotein E has been implicated in modifying neurological outcome after traumatic brain injury, although the mechanisms by which this occurs remain poorly defined. To investigate the role of endogenous apolipoprotein E following acute brain injury, noninvasive magnetic resonance imaging was performed on anesthetized mice following closed head injury. Effacement of the lateral ventricle was used as a radiographic surrogate for cerebral edema. At 24 hours following injury, apolipoprotein E-deficient animals had a greater degree of cerebral edema as compared to matched controls. In addition, the brains of apolipoprotein E-deficient animals had a significantly greater upregulation of tissue necrosis factor alpha messenger ribonucleic acid as compared to controls as early as 1-hr post injury. Thus, modulation of the endogenous central nervous system inflammatory response may be one mechanism by which apolipoprotein E affects outcome following acute brain injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782990     DOI: 10.1002/ana.10098

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

Authors:  H N Dawson; V Cantillana; M Jansen; H Wang; M P Vitek; D M Wilcock; J R Lynch; D T Laskowitz
Journal:  Neuroscience       Date:  2010-04-29       Impact factor: 3.590

2.  Apolipoprotein E e4 allele does not increase the risk of early postoperative delirium after major surgery.

Authors:  Fernando José Abelha; Vera Fernandes; Miguela Botelho; Patricia Santos; Alice Santos; J C Machado; Henrique Barros
Journal:  J Anesth       Date:  2012-02-01       Impact factor: 2.078

3.  Hormonal modulators of glial ABCA1 and apoE levels.

Authors:  Jianjia Fan; Yoko Shimizu; Jeniffer Chan; Anna Wilkinson; Ayaka Ito; Peter Tontonoz; Edie Dullaghan; Liisa A M Galea; Tom Pfeifer; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 4.  Delirium: an emerging frontier in the management of critically ill children.

Authors:  Heidi A B Smith; D Catherine Fuchs; Pratik P Pandharipande; Frederick E Barr; E Wesley Ely
Journal:  Crit Care Clin       Date:  2009-07       Impact factor: 3.598

5.  Effect of APOE Gene Polymorphism on Early Cerebral Perfusion After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Chongjie Cheng; Li Jiang; Yanhong Yang; Haitao Wu; Zhijian Huang; Xiaochuan Sun
Journal:  Transl Stroke Res       Date:  2015-09-14       Impact factor: 6.829

6.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

Review 7.  Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery.

Authors:  Elayna Kirsch; Natalia Szejko; Guido J Falcone
Journal:  Neurosci Lett       Date:  2020-05-26       Impact factor: 3.046

Review 8.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

Review 9.  Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Authors:  Diewertje I Bink; Katja Ritz; Eleonora Aronica; Louise van der Weerd; Mat J A P Daemen
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

10.  A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Authors:  Junling Gao; Haichen Wang; Huaxin Sheng; John R Lynch; David S Warner; Lori Durham; Michael P Vitek; Daniel T Laskowitz
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.